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Abstract: 
Introduction: Hypertension significantly increases the risk of mortality and 
morbidity of cerebrovascular accidents (both ischaemic and haemorrhagic), 
coronary artery disease, congestive heart failure, chronic kidney failure, and 
peripheral vascular diseases. Hypertension related complications have become 
one of the most important contributor to preventable deaths and diseases in our 
country too, with an alarmingly increasing rate in the rural areas. More than 140 
million people are said to be suffering from hypertension in India and it has 
been estimated to overhaul the 214 million mark by 2025. 
Settings and Design: A case-control study involving 100 subjects. Subjects 
were grouped into 50 healthy controls and 50 cases of essential hypertension. 
Concentrations of serum total calcium and serum calcium phosphorus ratio were 
measured in the participants and compared in hypertensive patients and 
normotensive individuals. 
Results: The study showed that serum total calcium were significantly 
decreased (p Value <0.001) and serum calcium phosphorus ratio is increased (p 
Value <0.001) in hypertensive patients as compared with normotensive 
individuals. 
Conclusions: Essential hypertension has an inverse association with serum total 
calcium and positive correlation with calcium phosphorus ratio which suggests 
a major role in the pathogenesis of essential hypertension.  
Keywords: essential hypertension, serum total calcium, serum calcium 
phosphorus ratio  
1. Introduction 
Hypertension is an increasingly important medical and public health burden  
globally. Worldwide, hypertension is estimated to cause 7.7 million 
deaths,which is  about 12 – 15 % of all total deaths. 
Hypertension significantly increases the risk of mortality and morbidity of 
cerebrovascular accidents (both ischaemic and haemorrhagic), coronary artery 
disease, congestive heart failure, chronic kidney failure, and peripheral vascular 
diseases. Hypertension related complications have become one of the most 
important contributor to preventable deaths and diseases in our country too, with 
an alarmingly increasing rate in the rural areas. More than 140 million people 
are said to be suffering from hypertension in India and it has been estimated to 
overhaul the 214 million mark by 2025. The World Health Organization 
estimated in 2008 that 33 %  men and 32 % women older than 25 years in India 
suffer from hypertension. 
Cardiovascular diseases resulted in over 2.3 million deaths in India in 1990. 
This is expected to double by the next decade in the country. It has been clearly 
established that Hypertension alone is directly responsible for 57% of all 
cerebrovascular accident deaths and 20-24 % of all cardiovascular deaths in 
India. 
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FIG 1: GLOBAL DISTRIBUTION OF HYPERTENSION (WHO 2008) 
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An Integrated Disease Surveillance Prevalence Survey in 2007-08 indicated that 
a large number of populations in India are in pre-hypertension category. 
Mizoram showed 58.5 % people in pre-hypertension stage. However, the actual 
percentage of  population suffering from hypertension was modest comprising 
of only 19 %. Other states in descending order of prevalence of pre-
hypertension were Uttarakhand (48.8 %), Kerala (48.10 %) and Maharashtra  
(46.2 %) respectively. MP, Tamil Nadu and AP are the other States that have 
over 40 % of the population in the pre-hypertension stage. The list is given 
below in the chart. 
 
FIG 2: STATES IN INDIA WITH HIGH PREVALENCE OF 
PREHYPERTENSION STAGE 
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FIG 3: PREVALENCE OF PRE-HYPERTENSION POPULATION IN 
SOUTH INDIA 
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Primary hypertension has remained a major modifiable risk factor for 
cardiovascular disease even though tremendous advances have been made in 
understanding its pathogenesis and effective treatment guidelines have been laid 
down by the medical fraternity. Hypertension increases the risk of 
Cardiovascular disease for millions of people globally, a contradiction in the 
face of modern medicine and worse, it is increasing at an alarming rate. 
 Essential hypertension is that type of hypertension where all the secondary 
causes have been ruled out. It comprises of 85-95% of adults hypertension. 
Essential hypertension is that type of hypertension, for which,  no cause can be 
identified, affecting around 95% of  all hypertensive individuals. 
 
FIG 4: CAUSES OF HYPERTENION IN ADULTS 
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The primary characteristic of essential hypertension is an increased tone in 
vascular smooth muscle which results in an increase in total peripheral 
resistance. 
 It has been postulated in many studies is that changes in the serum calcium  is 
the key regulator in the contraction of vascular smooth muscle cells. Therefore, 
Any situation which is associated with an increased strength of  smooth muscle 
contraction must either alter the Calcium level itself, change the behaviour of 
the contractile apparatus to Calcium, or exert both effects.  
Apart from its role in the contraction of vascular and cardiac smooth muscle, 
Calcium also plays a major role as an intracellular messenger in the response to 
noradrenaline, adrenaline, and angiotensin, the release of noradrenaline, the rate 
of secretion of aldosteron by adrenal glomerulosa cells, and probably the release 
of renin from juxtaglomerular cells. Furthermore, many vasodilatory and other 
antihypertensive agents exert calcium dependent mechanisms, their effects by 
interference with or by reduction of intracellular calcium concentration. 
Whatever mechanisms are involved in the pathogenesis of primary hypertension 
the final consequence must be, in all likelihood, a disorder of cellular calcium 
mechanism or, more specifically, in the functioning of the cell membrane. In  
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recent years a various models of  calcium metabolism involving cellular calcium  
level, membrane binding transport, altered premeability and transport kinetics,                                                                   
have been described in individuals with hypertension and in animal models as 
well. Also, many studies have suggested that general calcium handling may be 
altered in essential hypertension. These findings indicate a likely role for the 
calcium ion in the pathophysiology of essential hypertension.  In this study, we  
attempt to  review the evidence that altered calcium metabolism, thereby change 
in serum calcium levels  are implicated in primary hypertension. 
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Epidemiology: 
The incidence and prevalence of hypertension varies among different countries 
and geographical regions or even communities within  a country. In India urban 
areas have higher prevalence rate as compared with rural areas. However, recent 
data suggests that the trend is changing during the last three decades. In adults, 
diastolic BP increases with age till 50 – 60 years of age, after which, it follows a 
decreasing pattern.  
Recent studies had indicated that over 1 billion adults had high blood pressure 
in 2000, which is expectedted to increase to 1.56 billion by 2030. The 
prevalence of high blood pressure in the l9th and 20th centuries was variable in 
different studies in India, which ranged from 3-16% in Urban population and 3-
7% in Rural population. Review of recent data indicate that prevalence of high 
blood pressure is increasing exponentially in both urban and rural population 
and currently is 20-25% in small towns and cities and 10-16% in villages. The 
global status on Non Communicable Diseases report in 2011 showed that  over 
2.6 million deaths occurred from Cardiovascular disease alone in our country in 
2008, mainly from coronary artery disease and cerebrovascular accident. 
Several surveys on the prevalence of high blood pressure in India has been done  
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since post – independence era. In fact, one of the earliest well known study was 
done in 1963 by Mathur and associates at Agra in the urban population. Since 
then, many regional and national studies have been done in both rural and urban 
population. Some of the earliest as well as most recent studies done in India are 
mentioned below in the table. 
 
 Table 1: Post-Independence era studies from 1963 – 1999 on prevalence of 
hypertension in Urban adults of India 
 
Authors 
 
Area 
 
Year 
 
Age 
 
Prevalence  
 
 
Prevalence 
 
Men 
 
 
Women 
 
%age 
 
 
sample 
 
%age 
 
sample 
Mathur Agra 1963 >20 3.98 1408 6.64 227 
Malhotra Railways 1970 20-58 6.2 2638 ---- ---- 
Gupta Rohtak 1978 >20 6 1151 7 872 
Chaddha New Delhi 1990 25-64 11.66 637 13.68 17351 
Gupta R Jaipur 1995 >20 30 1415 34 797 
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 Table 2 : Recent studies from 2000 – 2012 on prevalence of hypertension in 
Rural adults of India 
 
 
Authors 
 
Area 
 
Year 
 
Age 
 
Prevalence  
 
 
Prevalence 
 
Men 
 
 
Women 
 
%age 
 
 
sample 
 
%age 
 
sample 
Gupta SP Haryana 1977 20-69 3.5 1154 3.69 891 
Baldwa Rajasthan 1984 >20 6.93 447 8.81 465 
Jajoo Maharashtra 1993 >20 2.89 2247 4.06 1789 
Agarwal UP 1994 >20 1.57 3760 ---- ---- 
Malhotra Haryana 1999 16-70 3.0 2259 5.80 ---- 
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 Table 3 : Recent studies  from 2000 – 2012 on prevalence of hypertension in 
Urban adults of India 
 
Authors     Year 
 
Area 
 
Age (yr) 
 
Sample Size 
 
Prevalence(%) 
Anand MP    2000 Mumbai      30-60 1662                 34.0 
 Gupta PC     2004 Mumbai  ≥ 35 88653                        47.9 
Prabhakaran    2005 Delhi 20-59 2935                        30.0 
Reddy KS      2006 National 20-69 19973                        27.2 
Mohan V      2007 Chennai  ≥ 20 2350                        20.0  
Kaur P      2007 Chennai 18-69 2262              27.2 
 Yadav S      2008 Lucknow  ≥ 30 1746                        32.2 
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 Table 4 : Recent studies  from 2000 – 2012 on prevalence of hypertension in 
Rural adults of India 
 
Author 
 
Year 
 
Area 
 
Age (yr) 
 
Sample 
 
Prevalence(%) 
Hazarika 2004 Assam >30 3180 33.3  
Thankappan 2006 Kerala >30 2159 36 
 Krishnan  2008 Harayana 15-64 2828 9.3  
Todkar SS 2009 Maharashtra  ≥ 20 1297 7.2  
Vijaykumar 2009     Kerala  ≥18 1990 36.1  
Bhardwaj  2010 Himachal  ≥ 18 1092 35.9  
Kinra  2010 National 20-69 1983 20.0 
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 Factors responsible for the increasing trend of hypertension has been attributed 
to increased longevity, lifestyle modifications, example sedentary life, obesity, 
less physical work, etc., dietary changes like smoking, high fat content, 
increased salt intake, environmental and genetic factors. 
Despite the high prevalence rate of hypertension in India, awareness of 
hypertension and its implications is still low among the general population and 
the patients seeking treatment for hypertension, still lower. Preventive measures 
and mass education at grass root level is in need today to deal with hypertension 
which has become a national health burden. 
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DEFINITION AND CLASSIFICATION: 
 In clinical terms, hypertension is defined as that level of blood pressure at 
which the institution of therapy reduces blood pressure related morbity and 
mortality.  
Currently, the criteria for defining hypertension is based on  average of 2 or 
more blood pressure readings in sitting position in at least  two outpatient visits. 
The current recommended criteria for diagnosis of hypertension at home is the 
average awake blood pressure of more than 135/85 mmHg and asleep blood 
pressure of more than 120/75 mmHg which are roughly equal to a clinic blood 
pressure of 140/90 mmHg. 
Classification of Hypertension: 
JNC – VII Classification: American Medical Association 
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Prehypertension per se is not a disease category. Rather it is a term used to 
recognize individuals who are at high risk of developing hypertension so as to 
facilitate the awareness to both the patient and clinician to the risk and proper 
strategies implemented to prevent or delay the disease from progressing further. 
Such persons should ideally be advised to change lifestyle and diet to minimize 
the risk of high blood pressure in their later lives. 
On the other hand, individuals with prehypertension  who also have other 
associated comorbitities should be started with appropriate drug therapy if their 
blood pressure remains elevated more than 130/80 mmHg . 
Several terms have been coined by various authors for describing hypertension 
associated with specific conditions or settings. 
White coat Hypertension    - Hypertension in the hospital/clinic 
Systolic Hypertension                 - Systolic BP more than 140 mmHg  but less            
than 80 mmHg diastolic (probably age related)  
Malignant Hypertension             - Very high Blood Pressure with signs of end  
organ damage 
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 Labile Hypertension                   - Blood Pressure which shows variable  
readings    
Accelerated Hypertension           - very high Blood Pressure detected recently  
 Pseudo Hypertension                  - High blood pressure due to atherosclerosis 
Pulmonary Hypertension            - High Blood Pressure due to congestion in  
the lungs 
 Renovascular Hypertension        - High blood pressure owing to narrowed  
blood vessel in the kidney  
 Pre-eclampsia                             - High blood pressure induced by pregnancy 
Secondary Hypertension            - Hypertension due to a known causating  
factor 
Borderline Hypertension             - Blood Pressure in the grey zone 
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 RISK FACTORS: 
Age: The risk of hypertension increases through middle age (>50 years) and  
is slightly more common in men. Women are more likely to develop high 
blood pressure after age 65 i.e., post menopausal age. 
Smoking:  It induces arterial stiffness, lipid modification and endothelial 
dysfunction. Smoking leads to transient elevation of systolic BP by 10-20 
mmHg with a single cigarette which in turn elevates the average daytime 
BP. 
Alcohol: The risk of hypertension is slightly lower in moderate drinkers (< 2 
drinks/day) than teetotalers. However it is increased in heavy drinkers (> 3 
drinks/day). 1 drink being equal to about 13 gm of alcohol. The mechanism 
of alcohol leading to hypertension is not exactly known. Some possible 
mechanisms are increased sympathetic activity, impaired baroreceptors, 
increased cortisol levels and activation of rennin-angiotensin-aldosterone 
pathway. 
Dietary habits: Increased salt intake leads to retention of fluid and rennin-
angiotensin system stimulation, thereby  increasing the incidence of 
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  hypertension. Recent studies have shown that hypertension is associated 
with low vitamin D. Also, High dietary content in fat and carbohydrate has 
been linked with increased α1 and β adrenergic receptors causing increased 
sympathetic activity. 
Body mass index: Hypertension prevalence increases linearly with increase 
BMI. Obese individuals have increased norepinephrine turnover in 
peripheral tissues, impairment of pressure natriuresis, structural changes in 
the kidneys, endothelial dysfunction and changes in vascular tone. 
Genetics: Concordance of blood pressure is significantly higher in families 
than in individuals not related by family, higher between monozygotic than 
dizygotic twins and higher between biological than adoptive siblings living 
in the same household. Several mutations in the gene have been implicated 
in the development of hypertension in susceptible individuals. For example, 
single gene mutations like Angiotensinogen gene, Glucorticoid receptor 
gene, Congenital adrenal hyperplasia, Lipoprotein lipase gene, and Multiple 
gene mutations include genes encoding for Renin–angiotensin–aldosterone 
system, Cellular ion-transport systems (Na–Li; Na–H; Na–K–Cl), Insulin 
resistance, Metabolic syndrome, etc have been associated with hypertension. 
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 In 90-94% of the individuals, a single reversible cause of hypertension 
cannot be identified, hence the term idiopathic hypertension. Among the 
remaining 5-10%, a more discreet cause can be pointed at, which is then 
called secondary hypertension. 
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 MECHANISM OF ESSENTIAL HYPERTENSION 
Some mechanisms implicated in causing hypertension are: 
Genetic predisposition: It has been postulated that hypertension is a 
representation of polygenic disorder where in, a combination of genes acts in 
association with environmental and demographic factors. Several methods 
including animal models have been studied to identify the genetic loci and genes 
associated with hypertension. Current studies suggest the likelihood of various 
gene mutations which may be responsible for the development of hypertension. 
Some of the genes which have been exclusively studied in this regard are genes 
encoding for  rennin-angiotensin-aldosterone system, alpha adducin, β 
adrenoreceptor, angiotensinogen 1 receptor, aldosterone synthase, lipoprotein 
lipase , and epithelial sodium channel in Liddle syndrome .  
Foetal environment: Low birth weight as a result of foetal malnourishment has 
been repeatedly found to be followed by an increased incidence of hypertension 
in later life with an overall estimate that 1 kg lower birth weight is associated 
with 2-4 mmHg higher systolic blood pressure in adulthood.  
Renin-angiotensin system:  Approximately, 20% of the patients who have 
hypertension have suppressed plasma rennin activity.  
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 They display increased retention of sodium with suppression of rennin owing to 
increased production of an unknown mineralocorticoid. They have higher salt 
sensitivity to blood pressure and respond to diuretics. Additionally, in some 
studies, when patients were categorically placed based on renin-Na, serum 
calcium was distinguishably different among different subgroups. Lower serum 
calcium was seen in Low renin subgroup and vice-versa. Of importance, 
angiotensin II, which activates angiotensin II type 1 receptor and stimulates 
aldosterone production, induces cardiac as well as vascular hypertrophy and 
hyperplasia. 
Vascular reactivity and remodelling: Hypertensive patients show greater 
response to norepinephrine than normotensive individuals. The downregulation 
of noradrenergic receptors is impaired in hypertension. As expected, alpha and 
beta adrenergic antagonists reduce blood pressure effectively thus indicating the 
role of sympathetic system in hypertension. There is evidence of alterations in 
structure, function and mechanical properties of small vessels. 
Endothelial dysfunction: Nitric oxide, a potent vasodilator, which is released 
by endothelial cells in response to changes in blood pressure, is decreased in 
hypertensive patients. 
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 Sympathetic nervous system: Hypertensive patients have increased 
sympathetic activity with decreased parasympathetic tone. Alteration in 
baroreceptor and chemoreceptor pathways occur both at central and peripheral 
levels resetting to a higher pressure. Conversely, this resetting is reversed when 
blood pressure is brought down to a lower or normal level with antihypertensive 
drugs. 
Intravascular volume:  Sodium, primarily an extracellular ion, is responsible 
for extracellular fluid volume which influences blood pressure over long term. 
Excess sodium due to decreased excretion via kidneys leads to hypertension as 
higher blood pressure is required to achieve sodium balance. 
Inherited cardiovascular factors and hyperinsulinemia: Approximately, 
40% of the hypertensive patients have hypercholesterolemia. There is a strong 
association between hypertension and type 2 diabetes mellitus.  
Hyperinsulinemia in hypertension arises as a consequence of insulin resistance 
to the peripheral utilisation of glucose. In obese as well as 20% of non obese 
hypertensive individuals, insulin resistance is noted and decreased hepatic 
uptake of insulin which contributes to hyperinsulinemia. 
 
      23 
 Altered calcium metabolism: Essential hypertension is associated with altered 
calcium metabolism. Changes in the regulation of intracellular free Calcium and 
disturbed extracellular calcium homeostasis are noted in patients diagnosed with 
primary hypertension. Extracellular calcium provides calcium ions for the 
maintenance of intracellular calcium levels, blood coagulation, bone 
mineralization and plasma membrane potential. It is widely accepted that the 
increase in peripheral vascular tone that characterises the established phase of 
hypertension is due to increased active tension in the smooth muscle cells. 
Calcium influx through receptor and voltage-gated calcium channels initiates 
vascular contraction and the fall in the intracellular free calcium concentration  
results in relaxation or vasodilatation. 
SECONDARY HYPERTENSION 
It is the arterial hypertension of known etiology.  It constitutes 5-10% of  all 
hypertension. Some common causes of secondary hypertension are given below: 
Kidney: Parenchymal kidney disease, Renal vascular pathology, malignancy, 
Liddle's syndrome, polycystic kidney disease, nephritic syndrome 
Endocrine: Acromegaly, Hyperthyroidism, Hypothyroidism, Cushing syndrome,  
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Hyperparathyroidism, Primary aldosteronism, Pheochromocytoma, Carcinoid 
syndrome 
Drugs and Substance abuse like NSAIDs, oral contraceptive pills, alcohol, 
cocaine, anabolic steroids 
Neurologic: Increase intracranial pressure, familial dysautonomia, Obstructive 
sleep apnea 
Coarctation of the aorta and Diseases of the aorta 
Pregnancy induced hypertension 
 
NATURAL HISTORY OF UNTREATED HYPERTENSION: 
In untreated hypertensive individuals, as the age progresses, Systolic blood 
pressure increases while diastolic blood pressure falls.  The risks associated with 
high blood pressure are more firmly associated with systolic blood pressure than 
to diastolic blood pressure in the individuals who are over the age of 60 years. 
SYMPTOMS AND SIGNS 
Patients with uncomplicated hypertension are mostly asymptomatic and many 
are unaware of the disease. Some patients may complain of headache, dizziness, 
tinnitus, palpitations, feeling of faint, all of which, may be encountered even in  
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normotensive patients. 
PATIENT’S RELEVANT HISTORY 
Clinical history should include the following assessments: 
 Previous history and duration of hypertension 
 Personality and social life 
 Family history of hypertension as well as cardiovascular disease 
 Risk factors:  Diet, drugs, addiction habits ( smoking, alcoholism, etc), 
Sedentary lifestyle, Obesity, other co-morbidities (diabetes, 
dyslipidaemia, etc) 
 Features of secondary hypertension: 
− Kidney disease: urogenital infections, haematuria, Chronic       
analgesic users,  autosomal polycystic kidney; 
− Pheochromocytoma: episodic occurence of diaphoresis, 
headaches, anxiety, Flushing, palpitations. 
 − Hyperaldosteronism: episodic weakness of  muscles, tetany 
 − Medication or substance abuse: oral contraceptive pills, 
liquorice, carbenoxolone, cocaine abuse, amphetamines, nasal 
drop, corticosteroids, NSAIDS 
 Features of target end-organ damage: 
− Central Nervous System: headaches, Giddiness, Decreased 
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 visual acuity, transient ischemic attack, Focal neurological 
deficits; 
− Cardiovascular system: Breathlessness, palpitations, chest pain, 
pedal oedema 
− Kidney: excessive  thirst, polyuria, nocturia, dark/brown 
coloured urine 
 − Peripheral arteries: cold extremities, intermittent claudication. 
 
PATHOLOGIC CONSEQUENCES OF HYPERTENSION: 
Hypertension is a well known risk factor for all the clinical manifestations 
associated with atherosclerosis. It is an independent predisposing factor of 
congestive heart failure, coronary heart disease, cerebrovascular accident, kidney 
disease and peripheral vascular diseases. 
 
Effects on Cardiovascular system: 
Cardiovascular complication is the most common cause of death in 
patients with high blood pressure. Increased systemic pressure imposes 
excessive workload on heart. At first heart compensates by increase in wall 
thickness of left ventricle leading to concentric left ventricle hypertrophy.  
      27 
This is followed by left ventricular dysfunction, left ventricular cavity 
dilatation and congestive cardiac failure ensues. Anginal chest pain 
usually appear because of the following combinations:  
1. Accelerated atherosclerosis 
2. Increased myocardial oxygen demand as a result of 
increased left ventricular mass. 
Hypertension is a major risk factor for myocardial infarction and ischemia. 
Prevalence of silent MI is significantly increased in hypertensive subjects 
and they have a greater risk for mortality after an initial MI. 
 
Effects on Nervous system: 
Neurological effects of long standing high blood pressure can be divided into 
retina related changes in the central nervous system. Retina is the only tissue 
in the body which the blood vessels can be examined directly. Funduscopy 
examination gives the opportunity to study the vascular effects of 
hypertension. A useful guide is the Keith Wagener Barker classification of 
fundoscopic changes.  
High blood pressure is directly associated with increased risk of 
cerebrovascular accidents (both ischaemic and haemorrhagic). The incidence 
of cerebrovascular accidents increases progressively with increased blood 
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 pressure level, especially systolic B P  in patients who are more than  65 years. 
Hypertension may accelerate brain function decline with age. Blood 
flow in the brain usually remains unchanged within a wide range of 
arterial pressure through a process termed auto-regulation of blood flow. 
In patients with malignant hypertension there is failure of auto-regulation 
system of cerebral blood flow resulting in vasodilation and excessive 
perfusion. 
With severe hypertension, hypertensive encephalopathy may occur which 
manifests as severe headache, nausea with or without projectile vomiting, 
focal neurological deficits, and altered sensorium. It is a medical emergency 
and if immediate treatment is not provided, patients may progress to stupor, 
coma, seizure, or even death. 
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Effects on kidney : 
High blood pressure is a well known risk factor for kidney injury and chronic 
renal failure. The risk of kidney injury appears to be more closely related to 
systolic r a t h e r  than diastolic blood pressure. Whether the injury is  due to 
primary or secondary hypertension, it c a u s e s  d a m a g e  t o  t h e  renal 
arterioles  which is also known as hyaline arteriolosclerosis that ultimately 
progresses and cause loss of function. Sclerotic lesion of both the afferent 
arteriole and efferent arteriole along with glomerular capillary tufts is the most 
common finding among the renal vascular lesions in patients with high blood 
pressure which leads to reduction of glomerular filtration rate and loss of  tubular 
function. 
Renal disease may manifest as a mild to moderate elevation of serum 
creatinine concentration, microalbuminuria, or proteinuria. Microalbuminuria 
in hypertensive patients has been correlated with LVH and carotid 
artery thickness. Any agent or group of agents that adequately lowers BP 
to levels less than 130/85 mm Hg will delay the progression of nephropathy. 
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FIG 5: FLOW CHART OF STRESSOR AND EFFECT IN HYPERTENSION 
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FIG 6: COMPLICATIONS OF HYPERTENSION 
 
 
 
 
 
      32 
 EVALUATION OF A HYPERTENSIVE PATIENT: 
Evaluation of patients with high blood pressure has the following objectives: 
 
1.To study the lifestyle and identify other cardiovascular risk factors or 
associated disorders that may later influence the prognosis and treatment. 
 
2. To look for the cause or causes of high blood pressure and if identified, 
formulate a strategy of treatment. 
 
3. To evaluate the presence or absence of end organ damage and Cardiovascular 
diseases. 
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 Physical examination: 
Some of the examination which should be included routinely are: 
 Measurement of blood pressure using correct technique and apparatus, 
measurement and comparison of the contralateral arm, 
 Examination of fundus , 
  Body mass index (to be calculated as weight in kilograms divided 
by square of height in metres. 
 Waist – hip ratio and circumference 
 Auscultation for abnormal sounds in the arteries such as carotid bruit, 
abdominal bruit and femoral bruit,  
 Examination of Thyroid gland (to rule out thyrotoxicosis and 
tumours) 
 Examination of cardiovascular system  
 Examination of respiratory system,  
 Examination of abdomen for palpable kidney, tumours and 
abdominal aortic pulsations.  
 Palpation of the lower limbs for pedal/ankle oedema and lower limb 
pulses along with complete neurological assessment. 
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FIG 7: SYSTEMIC EVALUATION OF A HYPERTENSIVE PATIENT  
 
      35 
 Biochemical Investigations: 
 
1. Urine analysis: Protein, Blood, Glucose, Microscopy 
2. Haematocrit 
3. Fasting glucose 
4. Serum Creatinine and Blood Urea Nitrogen 
5. Serum calcium, phosphorus and other electrolytes 
6. Lipid profile that including Total cholesterol, HDL 
Cholesterol, LDL Cholesterol and Triglycerides. 
7. Electrocardiogram 
8. Echocardiogram 
Hence it is evident that urine albumin excretion is one important 
parameter which should ideally be included in the Evaluation of 
hypertensive patient. 
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 CALCIUM : 
Calcium is the most abundant mineral in the human body. A normal healthy 
adult body contains a total calcium of roughly 1 kg, 99% of which, are present in 
the bones in the form of calcium phosphate salts. The extracellular fluid  
contains around  22.6 mmol, out of which about 9 mmol is found in the 
serum. Almost 500 mmol of calcium is exchanged between bone and the 
Extracellular fluid daily. Serum level of calcium is tightly regulated with 
normal total calcium of 8.07-10.2 mg/dl and a normal ionised calcium of 4.4-
5.5 mg/dl. The amount of total calcium varies a c c o r d i n g l y  with the level of 
serum albumin to which calcium is bound. The biological effects of calcium 
in the body are influenced by the content of ionised calcium, rather than the 
total calcium. Ionised calcium does not vary with the albumin level, and 
therefore it is an advantage to measure the level of ionised calcium whenever  
serum albumin is expected  to  vary or  any pathological condition that 
changes serum albumin concentration or a pre-existing calcium disorder is 
suspected in the patient. 
 
Dietary sources of Calcium: 
Some products containing high calcium in India are mentioned below. 
 Milk (skimmed > whole) 
37 
 Cheese 
 Soya beans, broccoli, spinach,  
 Dried fruits and nuts 
 Yoghurt 
 Figs, Oranges 
 
Calcium metabolism: 
The mechanism of calcium homeostasis is complex and diverse, involving 
calcium itself and other related minerals such as magnesium and 
phosphorous, and three calcitropic hormones-parathyroid hormone, calcitonin, 
and active form of vitamin D3 which is 1,25 dihydroxy cholecalciferol. 
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 FIG 8: CALCIUM HOMEOSTASIS IN THE BODY 
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 There are three principal organs involved in calcium homeostasis: 
 
 Gastrointestinal tract 
 
 Bone  
 
 Kidney 
 
 
Gastrointestinal tract: 
   
Intestinal absorption of calcium is mediated by two mechanisms: 
 
 An active process, regulated by calcitriol     
  (1,25- dihydroxycholecalciferol)  
 
 A passive process 
 
 
 
Active process involves a calcium binding protein whose synthesis is 
 
increased by calcitrol. It occurs mainly in duodenum and upper jejunum. 
Calcium enters the luminal surface of the cells through specific apical calcium 
channels, whose number is regulated. It then moves across the cell membrane 
in association with a specific calcium binding protein (calbindin). Ca2+-
ATPases and Na/Ca exchangers actively extrude calcium across the 
basolateral surface and ther eby maintain the transcellular calcium gradient. At 
high levels of calcium intake, synthesis of calcitriol is reduced, in turn decreases 
calbindin synthesis and decreases rate of active intestinal calcium absorption. The 
opposite occurs with decreased dietary calcium intake. 
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Passive process occurs in the small intestine and possibly in the colon. It 
approximates 5% of daily calcium intake. 
The absorption of calcium is influenced by other dietary constituents. The 
presence of anions such as phosphate, oxalates and phytates decrease 
calcium solubility and so its absorption. 
 
Kidneys: 
 
The ionized and complex fraction of plasma calcium is filtered at the 
 
glomeruli, amounting to approximately 250mmol per 24hr. Of this, about 
98% is reabsorbed, from the proximal tubules. Calcium reabsorbtion in the 
proximal tubules is a passive process and is closely linked with sodium and 
is not regulated by hormone. 
The fine tuning of calcium excretion is carried out in the distal parts of  
nephrons where nearly 15% of the filtered load is reabsorbed in the tubule. This 
region comprises of the distal convoluted tubule, the connecting tubule and the 
b e g i n n i n g  of the cortical collecting duct. Here, reabsorption is an active 
process and occurs against an electrochemical gradient. This active 
reabsorption is subject to hormonal regula tion -principally by parathormone, 
but also by calcitrol, calcitonin, oestrogens and androgens. 
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Bone: 
 
The influx of calcium into bone equals its rate of efflux and bone mass 
 
remains constant. But it is different in bone growth and senescence. Bone 
remodelling probably accounts for changes in bone density that takes place with 
ageing or disease. 
 
In a normal adult, about 5% of entire skeleton is remodelled in one year. In 
contrast radioisotope studies have indicated that 1-2 % of body calcium can 
be exchanged between the bone and ECF over a period of several days. 
 
 
FIG 9: SITES OF CALCIUM EXCRETION FROM THE BODY 
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 HORMONAL REGULATION OF CALCIUM METABOLISM: 
 
 
 
Regulation of calcium is given briefly in the diagram given below: 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
                         
       
 
 
FIG 10 : CALCIUM HOMEOSTASIS 
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 1. PARATHYROID HORMONE: The principal regulator of PTH secretion is 
the ECF ionized calcium content in the body, low level stimulates secretion 
and high level inhibits it. 
 
 
2. CALCITONIN: It is a 32 amino acid peptide chain secreted by the 
parafollicular C-cells present in the thyroid gland. Secretion of calcitonin is 
stimulated by an increase in plasma calcium concentration and is also released 
in response to some gut hormones such as gastrin, glucagon, secretin. It 
reduces plasma calcium concentration by decreasing calcium reabsorption from 
kidneys, decreases uptake from intestines and increases deposition in bones.  
 
 
3. VITAMIN - D: Vitamin D3, either ingested in a preformed state or 
synthesised in the skin by the action of ultraviolet light, is normally 
hydroxylated in the 25-position in the liver to form 25-hydroxyvitamin D3, the 
principal form of  vitamin in the circulation. 25-hydroxyvitamin D3 is normally 
hydroxylated in l-a position in the kidney to form 1, 25 dihydroxycholecalciferol, 
which is biologically the active form of vitamin. 
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Calcium metabolism in essential hypertension: 
 
Primary hypertension is strongly linked with altered calcium metabolism. 
Calcium ion acts as an intracellular second messenger in the contractility of 
cardiac muscle and smooth muscle cells. A rise in total peripheral vascular 
resistance is a common finding in all forms of hypertension irrespective of 
the causes. The free intracellular calcium level determines the tension in 
vascular smooth muscle cells which leads to in peripheral vascular resistance. 
Calcium affects on the peripheral vascular tone directly. 
 
  
Alterations in the level of intracellular calcium level are believed to be involved 
in the final common pathway which mediates the synthesis, secretion and action 
of many hormones, such as the pressure actions of catecholamines and 
angiotensin II . Calcium regulating hormones like 1,25dihydroxy cholecalciferol, 
renin level contribute to pathogenesis of primary hypertension. 
 
 
Several disturbances of calcium metabolism have been associated with 
 
hypertension. It has been suggested that low dietary calcium intake 
significantly increases the risk for hypertension. In addition, some 
hypertensive subjects appear to have lower serum calcium levels, increased 
urinary excretion of calcium i.e.hypercalciuria, raised intracellular calcium 
levels, and reduced cellular membrane calcium binding. 
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 PHOSPHORUS 
It is the sixth most abundant element in the human body. A normal healthy adult 
contains almost 700 g of phosphorus in the body, most of which, is located in the 
bones as hydroxyapatite (Ca₁₀(PO₄)₆(OH)₂). The remaining Phosphorus is present 
in extracellular fluid and soft tissue organs, mainly as part of proteins,  
Lipids, nucleic acids, phospholipids and nucleotides. 
FUNCTIONS: 
 Phosphorus is an essential nutrient in bone mineralization. 
  It is required in energy generation, cell signals via phosphorylation. 
 It provides structural integrity of phospholipids, various nucleotides, 
proteins, lipids and nucleic acids. 
  Intracellular phosphate is present in  many of the compounds that are 
phosphorylated compounds, like adenosine triphosphate , guanosine 
triphosphate ,etc.  which are important basic needs in metabolism of energy 
and activation of enzymes. 
  It acts as a buffer for both extracellular and intracellular compartments  
through the interchaange of HPO42- and H2PO4-, thus helping to maintain 
normal pH in the body. 
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 Dietary sources of Phosphorus: 
Some of the products rich in phosphorus found in India are mentioned below. 
1. Vegetable sources: Soya beans, Yellow/white beans, Lentils, Peas 
  Seeds of pumpkin, squash, watermelon 
Cashew nuts, almond, whole grains 
2. Animal sources:   Cheese and yoghurt 
Sea foods like salmon fish, oyster  and shellfish 
Pork liver and chicken liver 
 
PHOSPHORUS METABOLISM: 
Similar to calcium metabolism, the main Phosphorus regulation sites are:  
 
 The Digestive system ( for absorption), 
  The Renal system ( for excretion )  
   The Skeletal system ( for storage) 
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FIG 11 : PHOSPHORUS METABOLISM 
The main regulation occurs in the kidneys, and homeostasis is maintained by 
excreting Phosphorus via urine. In an average adult with normal dietary 
Phosphorus intake, approximately 6-7 g of Phosphorus is filtered daily by  kidney. 
More than 80% of Phosphorus is reabsorbed in the proximal convoluted tubule and 
the remaining 10% in the distal convoluted tubule and  around 10% is excreted via 
urine. Phosphorus in a human body is considered to be in balance when the output 
(loss of Phosphorus via urine, stools and sweat) is equal to that of the amount of 
Phosphorus absorbed which occurs through intestines.  
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             FIG 12: REGULATION OF PHOSPHORUS METABOLISM 
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 2. AIM AND OBJECTIVES  
 To study the levels of serum Total Calcium and serum Calcium / Phosphorus 
ratio in patients with primary hypertension. 
 To correlate the serum Total Calcium level  and serum Calcium / Phosphorus 
ratio with blood pressure  
 
 
STUDY POPULATION     
   A total of 100 subjects, of which 50 cases of essential hypertension satisfying 
inclusion and exclusion criteria visiting medicine OPD and admitted in 
Government Rajaji hospital, Madurai and 50 age and sex matched normotensive 
controls from 1
st
 June 2014 to 30
th
 November 2014 will be taken up for study.  
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 3.  REVIEW OF LITERATURE 
HISTORY 
 
Though Hypertension was believed to exist since antiquity it was possible to 
recognize it only after the discovery of a device to measure it. Blood circulation 
was discovered as early as the year 1616 by William Harvey. First report of 
direct blood pressure dates from 1726 by Stephen Hales who cannulated horse 
crural artery and assessed the height of blood column before and after 
hemorrhage. 
 
 
The monoaural stethescope was discovered by Lennac in 1819. Biaural 
stethoscope came to America in 1852. Vierordt, a German scientist was the 
first person to device an instrument to measure blood pressure in the year 
1853.Though this instrument was cumbersome he is the pioneer in establishing 
the principles of estimating blood pressure by obliterating the pulse which is 
followed even today. 
 
 
In the year 1896 Riva Rocci introduced the sphygmomanometer cuff. In the 
year 1905 Nikolai Korotkoff devised auscultatory method of measuring 
arterial pressure and measured diastolic and systolic pressure levels for first 
time. Evaluation of antihypertensive therapy began in 1920.Progress began  
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with arrival of thiazide diuretics in late 1960s. 
 
In the year 1986, H Kesteloot and J V Joossens conducted an epidemiological 
study on the association between food habits and cardiovascular risk factors. 
Serum sodium and Serum potassium, Serum calcium and serum  phosphorus, and 
total protein were measured in a total of 4167 men and 3891 women with a mean 
age of 49 years, and observed a very significant relationship between serum 
calcium, serum phosphorus with hypertension along with other cations. A random 
sample of the population was obtained in all Belgian counties by using the voting 
lists. A detailed dietary history was obtained from the participants by trained 
dietitians, and blood pressure was measured in the sitting position. Heart rate was 
measured at the time of blood pressure measurement. The results were submitted to 
multiple regression analysis using the stepdown method until all remaining 
parameters were significant at a p level below 0.05. Systolic BP and Diastolic BP 
were used as dependent variables. They concluded that the serum 
sodium/potassium ratio and the serum calcium/phosphorus ratio both correlated 
positively with blood pressure, whenever significant.  
  In the same year, A.R Folsom and his associates measured Serum 
calcium fractions in patients diagnosed with essential hypertension and matched 
normotensive candidates in a group of Minnesota population. The hypertensive 
group comprised 28 subjects whose diastolic blood pressure on both occasions was  
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greater than 90 mm Hg and who were not taking antihypertensive medication. One 
normotensive control was matched to each hypertensive subject. Controls were 
required to be of the same race and sex as the matched hypertensive subject and 
within 5 years of age. The hypertensive subjects had significantly lower serum 
ultrafilterable calcium levels (p = 0.01) and borderline significantly lower serum 
ionized calcium levels (p = 0.09) compared with levels in normotensive controls. 
Calculated serum concentrations of complexed calcium were also significantly 
lower in hypertensive subjects (p = 0.04). 
 
In the year 1987, R.M Touyz et al conducted a study on Johhanesburg  population 
among 296 male labourers and measured four parameters namely, serum calcium, 
serum magnesium, serum sodium and serum potassium. Of the total population 
studied, 82 were hypertensive, with a diastolic blood pressure (DBP) more than 95 
mmHg and/or a systolic blood pressure (SBP) more than 160 mmHg. Mean arterial 
pressure (MAP) was calculated from the standard formula: MAP = DBP + YJ 
(SBP - DBP). The hypertensive men were referred to the hypertension clinic at the 
local hospital for management. Detailed medical history including diet, lifestyle 
and Quetelet’s index was taken. Accuracy of techniques  of blood sample 
collection was established by using eight samples of serum and haemolysed red 
blood cells, the electrolytes of which, were measured weekly for 9 consecutive 
weeks. The samples were stored in a refrigerator at 4°C. The data were analysed  
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with an IBM 4331 computer at the Institute for Biostatistics of the South African 
Medical Research Council. Partial correlations showed a significant inverse 
relationship between serum magnesium and MAP (r = 0.575, P value <0.001*), 
erythrocyte magnesium and MAP (r = 0.329; P value < 0.001*), serum calcium and 
MAP (r =-0.309; P value < 0.001) and serum potassium and MAP (r = 0.157; P 
value  < 0.001*). This study showed that showed a significant decrease in serum 
calcium along with serum magnesium and potassium in the hypertensive subjects. 
They suggested the role of increased calcium influx causing vasoconstriction with 
a raised peripheral resistance and increased blood pressure. 
 
 
In 1992, Rachel H et al observed that disturbed calcium metabolism plays an 
important role in hypertension. They measured the indices of calcium metabolism 
in male participants who were previously not treated with elevated diastolic blood 
pressure and male participants matched for age with low diastolic blood pressure 
.The study population were drawn randomly from a community. They observed 
that Participants with high diastolic blood pressure had significantly higher level of 
parathyroid hormone concentrations than those participants with low diastolic 
blood pressure (p Value <0.01*). The 25-hydroxycholecalciferol and 1,25-
dihydroxycholecalciferol concentrations were comparable in both groups. 
Pparticipants with high diastolic blood pressure had lower total serum calcium 
which was statistically significant.( p Value  <0.01*). Parathyroid hormone levels   
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were compared with diastolic pressure. Thus they proved that participants who had 
higher diastolic blood pressure had lower total serum calcium which was 
statistically significant. 
 
Roberta M. Ray et al of American Heart Association conducted a study on effect 
of Calcium and Vitamin D supplementation on Blood Pressure in the year 2008. In 
this study, subjectss were randomly assigned in a double-blind fashion
 
to receive 
1000 mg of elemental calcium along with 400 IU of vitamin
 
D3 daily or placebo. 
Each active tablet provided 500 mg of
 
calcium (taken as calcium carbonate) and 
200 IU of vitamin D3. Subjects were instructed to take two
 
tablets daily, preferably 
in divided doses with meals. BP was measured by trained hospital staff using 
standardized procedures
 
and instruments, in the right arm, with a conventional 
manual mercury
 
sphygmomanometer and an appropriately sized cuff, after the
 
participant was seated and resting for 5 minutes. From baseline to the end of 
follow-up, systolic BP declined
 
by 1 mm Hg during follow-up, while diastolic BP 
declined by
 
4 mmHg. 
Michael B. Zemel in 2001 opined that regulation of intracellular calcium acts as a 
key role in hypertension
 
and obesity. Disruption of calcium homeostasis appears to
 
be a fundamental factor linking these conditions. Regulation
 
of intracellular 
calcium in key disease-related target tissues
 
by calcitropic hormones provides the 
opportunity to modulate
 
disease risk with oral Calcium in the diet. 
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Langford and Watson in 1987 were the first one to observe the inverse relationship 
between serum calcium and hypertension. In a study of 100 black women they 
found that individuals with low SBP (105mmHg) has consumed more calcium than 
others with high SBP (125mmHg).This study showed that calcium may be a 
protective factor in hypertension. 
 
In the year 2007, Abdelmarouf  H  Mohieldein et al compared the total serum 
calcium level in women who were pregnant and complicated with pre-eclampsia 
with those of  normotensive control in a case control study in 135 pregnant mothers 
in Sudan, out of which, 90 women with pregnancy  induced hypertension who 
were admitted after 20th week of pregnancy were taken as the study population. 
Serum calcium was measured using automated spectrophotometer. The study 
showed the mean serum calcium of the cases as 8.38 mg/dl ), and that of the 
control as 9.04 mg/dl which was significant statistically. Thus they concluded that 
decreased serum calcium level may contribute to the onset of pregnancy induced 
hypertension. 
 
In the year 2004 K. Sudhakar and associates conducted the first study in 
Indian population to show that calcium acts an important part in the pathogenesis 
of primary hypertension. The results of this study implied that serum calcium 
levels were significantly decreased in both males and female participants  
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 d i a g n o s e d  with primary hypertension and their first-degree relatives as 
compared with the normotensive individuals. This study proved that essential 
hypertension is strongly related with altered calcium metabolism. 
 
In the year 2011, Kamlesh Jha and associate examined Serum Calcium in 
Essential Hypertension and its corelation with severity of the disease   using 
Arsenazo ΙΙΙ method. The study showed that the mean serum calcium 
concentration of control subjects was found to be 2.53 + 0.08 mmol/l with a 
range of 2.37 to 2.70mmol/l. The females were found to have lower mean serum 
calcium level (2.5mmol/l + 0.08) than males (2.55 mmol/l +  0.07) but the 
difference between them was not statistically significant. The mean calcium 
values were found to be in agreement with recommended normal range of serum 
calcium concentration in both sexes. The mean serum calcium concentration of 
grade I hypertension cases was found to be 2.30 + 0.072mmol/l ranging 
between 2.16 to 2.58 mmol/l which was significantly lower (p<.0001) than that 
of control group but, was significantly higher (p=.009) than grade II 
hypertensive individuals (mean serum calcium level 2.25 + 0.09 mmol/l). Both 
grade I and Grade II hypertensive subjects of male and female sub-group 
showed significantly lower values of serum calcium than their respective control 
counterparts (p<0.0001 in all sub-groups). They concluded that both the stages  
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 of hypertension (Stages 1 and 2) showed significantly reduced serum calcium 
level in hypertensive individuals as compared with normotensive individuals. 
 
In the year 2012, Booloo Sharma and his associates evaluated a total of 345 
individuals from north eastern region of India irrespective of age and sex. The 
study population was divided into three main groups - Normal Control group 
consisting of 115 normal healthy subjects between 20-50 yrs of age, Experimental / 
Test group consisting 115 patients between 20 and 50 yrs of age  recently 
diagnosed with essential hypertension, not on medication, and free from any 
disease that might affect blood pressure or serum electrolyte level under study, 
First Degree Relative  group consisting of  115 first degree relatives of the Test 
group, who were between 20-50 yrs of age. Detail history including diet, lifestyle, 
medications, etc and physical examination was done prior to the study. Result 
values of test group and first degree relative group were compared with normal 
control group by  t test and probability (p) is calculated by observing values of  t  at 
a particular degree of freedom . The study showed that Serum Calcium level of test 
group have a significantly lower values as compared to the control subjects 
(p<0.001). The control group comprising of 115 individuals had a mean serum 
Calcium level of 9.26 ± 0.44 mg/dl, ranging from 8.4 mg/dl -10.1 mg/dl while the 
test group has a mean value of 8.23 ± 0.49 mg/dl, ranging from 7.6 mg/dl - 9.5 
mg/dl. 
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In 2012, Azin Alavi et al compared serum calcium level, serum protein level, and 
blood uric acid level between pregnant females who were hypertensive and 
normotensive in a cross sectional survey. They evaluated one hundred 
normotensive and forty eight hypertensive pregnant participants with single live 
foetus who were in ≥ 28 weeks of pregnancy for serum calcium level, total protein 
level, and blood uric acid level and compared the values between these two 
categories. All of the participants were at 28 weeks of pregnancy or above at the 
time of study and the participants of the two categories were matched for age, 
parity and Body Mass Index.  The Mean standard deviation of serum Calcium 
levels in normotensive and hypertensive participants were 8.28 (±0.77) mg% and 
7.88 (±0.94) mg%, respectively (P value < 0.01*). This study showed that Mean 
serum Calcium level was significantly lower in hypertensive pregnant women as 
compared with normotensive participants. They observed that higher serum 
calcium status in pregnancy favours decrease incidence of pre-eclampsia  and 
particular attention to nutritional diet should be encouraged in pregnant females 
with hypertension particularly in geographical areas that has high prevalence of 
malnutrition. 
In 2013, Saeed Behradmanesh and associate studied a population comprising of 60 
individuals and who were known cases of type 2 diabetes mellitus. Detail history 
along with anthropometric measurements and insulin doses were done in a cross 
sectional study. The diagnosis of hypertension in people with diabetes was  
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confirmed when the mean of at least two readings on minimum two clinic 
visitations was ≥ 130/80 mmHg.  They found a significant negative association of 
serum calcium with that of diastolic blood pressure. 
 
In the year 2014, Arpita B. Patel et al evaluated serum calcium in  150 individuals, 
50 of which, were first degree relatives of hypertensive individuals using an 
automated analyzer. They observed that the mean Standard deviation of serum total 
calcium levels in normotensives were 9.53 ± 0.51 and the same was found to be 
decreased in hypertensive groups (8.35 ± 0.63). They found that there was 
statistically significant difference between mean total calcium levels in males of 
hypertensives and normotennsives category. They also found that there was 
statistically significant difference between mean total calcium levels in females of 
hypertensives and normotensives category. When the first degree relatives were 
considered, the first degree relatives of hypertensives had statistically significant 
lower mean± SD serum total calcium levels (8.81 ±0.59), when compared to the 
first degree relatives of normotensive (9.33 ±0.45). P value is <0.05. The results 
confirmed that serum total calcium level and serum albumin level were 
significantly decreased in both sexes of participants with primary hypertension and 
their first degree relatives in comparison to their corresponding control while 
serum ionised calcium levels were not significantly different in hypertensives and 
their first degree relatives. 
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 In the year 2013, Takale and his associates studied the level of serum total and 
ionized calcium concentration in a group of 80 individuals  40 of whom, were 
normotensives using modified Arsenazo method was used for total calcium 
estimation . The results were expressed as mean  ± S.D. Comparison of control and 
test group  was done by unpaired T test. The results showed both serum total 
calcium level and serum free calcium level were decreased in hypertensive 
participants as compared to control thus concluding that decreased serum calcium 
levels suggest that calcium plays a crucial role in the pathophysiology of 
hypertension. 
In the year 1991, Talat J. Hassan et al studied the serum calcium, blood urea and 
uric acid levels in 150 female patients who were pregnant to establish the link with 
pre-ecclampsia. Detail history including diet, lifestyle, exercise, medications and 
hormones were taken. Out of the total participants, 50 were known cases of pre-
ecclampsia and 100 had normal blood pressure. They found the serum calcium 
level in pre-ecclampsia females to be 1.74 +/- 0.08 mmol/L while that of 
thatnormotensive females were 1.92 +/- 0.08mmol/L. Foetal age was calculated 
with ultrasonography. Their study observed low serum calcium was significantly 
low in pre-ecclampctic females which is associated with both maternal and foetal 
complications. 
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In the year 1998, Christina and Martinez noted that low serum calcium level is 
associated with hypertension and subjects who were supplemented with calcium 
had significantly reduced blood pressure. They suggested increased calcium 
supplementation in diet to prevent hypertension related complications, especially in 
pregnant women. 
In the year 2014, Kaushik Kar and his colleagues studied the level of serum total 
and serum ionised calcium in 47 subjects attending the outpatient department. 
Detail history of all the participants was taken. They observed that the mean 
standard deviation of the cases for serum total calcium was 1.032 mmol/L and that 
of the control was 1.157 mmol/L with p Value <0.001 thus concluding that 
hypertensive individuals had significantly low serum ionised calcium. 
In the year 1990, Zemel and associates observed that during pregnancy there are 
high risks of various maternal morbidity and complications among which one of 
the most common is the rise in blood pressure induced by the pregnancy, even 
though hypertension may not have been present before the pregnancy. The causes 
of this increase in blood pressure are not exactly known so far. However there has 
been an observation that reduction in the PGE2 levels is correlated to an increase in 
the vascular response to angiotensin II in pregnant women who are at risk to 
develop high blood pressure and large amount of proteins in the urine, most 
probably because of  the rise in intracellular ionic calcium. 
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In lieu of this, an extensive study was conducted by Julian A. Herrera et al., in the 
year 2006 to determine if the beneficial effect of oral supplementation of 
conjugated linoleic acid and calcium in the decrease of the instance of pregnancy-
induced hypertension , is related with differences in plasma levels of angiotensin 
II, renin, calcitropic hormones, prostacyclins, and plasma and intracellular ionized 
free calcium.  
For this particular study, the researchers studied 48 healthy women who were 
pregnant for the first time, and who also had a family history of  female relatives 
with a disorder during pregnancy characterised by large amount of protein in the 
urine and high blood pressure and instances of diastolic dip. Their blood samples 
were taken in a double blind format, with randomization and underwent placebo-
controlled trial. The representatives were from two different developing countries 
and selected from four random outpatient clinics.  
Basic calcium and conjugated linoleic acid placebo were orally administered daily 
in random to the subjects from week 18 to week 22 of gestation until the time of 
delivery.  
After the administration of the supplement and also the placebo, it was found that 
8.3% of the women who took the supplement experienced significantly decreased 
hypertension induced by pregnancy in comparison to 41.7% of women who  
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received the placebo. Another significant decrease was seen in the supplemented 
group  in concentration of intracellular ionized free calcium from 92.0nmol/L to 
 62.5nmol/L, from a range of 62.5-220nmol/L to 28-200nmol/L but not in the 
placebo group. However there were no significant changes seen in the 
concentration of plasma in ionized calcium, renin, parathomone, prostaglandin E2, 
angiotensin II and calcitonine. From the participants, 12 women developed high 
blood pressure induced by pregnancy and showed significant rise in the 
concentration of intracellular calcium. 
Therefore it has been concluded from the research findings and observations 
that intake of conjugated linoleic acid and calcium supplementation during 
pregnancy can significantly lower the instances of high blood pressure induced by 
pregnancy. It also reduces the concentration of intracellular ionized free calcium in 
peripheral blood lymphocytes.  
A comparative study was conducted recently in the year 2013 by Noran Jameel 
Ibhraheem and Dalia Shaker Obiade from Magazin of Al-Kufa University for 
Biology on the correlation between serum calcium level and high blood pressure 
during pregnancy, also termed as Pre-eclampsia. The research was done on healthy 
pregnant women from the province of Babylon. They were divided into two groups 
of participants; one included 35 participants who had slightly high blood pressure 
and the other, 30 participants who had very high blood pressure. The participants  
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were all from the Babylon maternity and paediatric teaching hospital. The data that 
were included during the collection were the blood pressure values, body mass 
index, maternal and gestational ages and also blood samples to analyze serum total 
calcium, serum albumin and serum ionized calcium.  
After the comparison it was observed that the blood pressure value and also the 
body mass index were much higher in the women with pre-eclampsia than in the 
women with normal blood pressure. It was also found that ionized calcium levels 
were much lower in the women with very high blood pressure induced by 
pregnancy as compared to pregnant patients with normal blood pressure and those 
pregnant patients with even slightly high blood pressure. The findings also show 
that the levels of serum total calcium and serum albumin were much lower in the 
pregnant women with very high blood pressure as compared to pregnant women 
with normal blood pressure. However it showed that the differences between 
slightly high blood pressure and normal blood pressure during pregnancy were 
negligible.  
This study confirms also that in order to predict the rise in blood pressure 
during pregnancy, tests must be done before the second and third trimesters of 
pregnancy because during the observations it was found that the total ionized 
calcium and serum albumin levels tested late had not much significance in the 
prediction of the rise in blood pressure. The researchers have also recommended 
further tests of other related vitamins along with serum calcium level which may  
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 contribute to this disorder called pre-eclampsia.  
In yet another study a representative sample of black women was taken to 
determine the level of serum calcium in the women who had hypertension induced 
by pregnancy before and 48 hours after the delivery and the results were compared 
to the serum calcium levels of black women with normal blood pressure during 
pregnancy.  
The sample included 127 women who were not pregnant and were not taking 
any medication or contraception, 102 women with normal pregnancies, and a study 
group with 27 eclamptic patients and 52 severe hypertensive patients. They were 
also grouped into pre-delivery and post-delivery groups. The blood samples 
obtained were analyzed to determine the levels of albumin, total protein, total 
calcium, phosphate, urea and magnesium.  
The results show that the mean of the diastolic blood pressure of the women 
who were not pregnant was much lesser than that of the women with normal 
pregnancies. Also both the mean of the systolic and diastolic blood pressures of the 
women with normal pregnancies were again much lesser than that of the study 
group of eclamptic and severe hypertensive patients.  
It was seen that the calcium levels between the women who were not  
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pregnant and that of the women with normal pregnancy did not have much 
differences. However, the calcium levels were much lower in those women who 
had eclampsia and sever hypertension, than as compared to the women who were 
not pregnant and those with normal pregnancies. Also when the results were 
compared between those women with eclampsia and those with severe 
hypertension, the former’s level of calcium were significantly lower than the 
latter’s. But not much differences were seen in the calcium levels in both the 
eclamptic and hypertensive groups when compared before and after delivery.  
Those women who had normal pregnancy did not show much differences in 
their ionized calcium levels before delivery and 48 hours after the delivery. There 
was also not much difference in the calcium levels between women who were not 
pregnant, who had normal pregnancies and who were severely hypertensive. After 
the second trimester, it was seen that the albumin level reduced significantly within 
those women who had normal pregnancies but the differences seen in the eclamptic 
and hypertensive after the second trimester women were quite negligible but was 
definitely lesser in comparison to the normal pregnancy women in each trimester 
and after delivery. There were also some differences in the levels of phosphorous 
and urea between these two groups but not in magnesium.  
One important observation concluded through this study was that the 
calculated ionic fraction of calcium was constant throughout the pregnancy but the 
total calcium level decreased. The calcium level decreased along with serum  
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albumin which shows that there is a strong correlation with protein-bound 
fractions. Through this study it has been proposed that the decrease in calcium 
level during pregnancy is because of physiological hypo-albuminaemia. The 
researchers have also suggested the further evaluation of ionized fraction of 
calcium because physiological changes during pregnancy make it hard to interpret 
the various levels of serum calcium concentration that takes place. The difficulty in 
interpretation is not only because of the physiological changes but also that serum 
calcium and albumin declines even more in pre-eclamptic patients, inferring to the 
increase in protein loss in urine.  
This study was also done in keeping with a hypothesis made by Mendlowitz 
that high blood pressure in pregnant women may be due to defective production of 
intracellular calcium-transporting protein in both the smooth uterus muscle and 
vascular muscle. This hypothesis is based on a demonstration on the Okimoto rat 
where a defect in the transport of calcium in the smooth muscle gave way to 
hypertension. 
The benefit of increase in calcium intake for hypertension can further be supported 
by another study undertaken by Dickinson Heather O et al., in the year 2008. The 
ongoing studies on metabolism suggest that calcium plays a role in the regulation 
of blood pressure. Some studies also have reported that people who take calcium at 
a higher level have lower blood pressure than others who do not. The debate and 
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 speculation still continues on whether or not supplementation of calcium orally 
contributes to the decrease in blood pressure. Therefore this study aims to analyze 
the effects of supplementation of calcium as a form of treatment in high blood 
pressure in adults. An extensive search for data was carried out in the Cochrane 
Library, EMBASE, ISI Proceedings, etc.  
The participants were all above 18 years of age, whose systolic blood pressure was 
140mmHg. Both the systolic and diastolic blood pressure values were monitored 
before and after the tests and at the end of follow-up. The participants who were 
pregnant were excluded from the study as well as those who were taking 
medication for high blood pressure, and also those who took calcium supplements 
with other medications. The subjects were taken in a randomized controlled trial 
where comparison was done among supplementation of calcium orally with usual 
care, no treatment or placebo. The test consisted of treatment and follow-up which 
took up 8 weeks.  
The data that were collected and the quality of the trial were analyzed and assessed 
separately by reviewers. For the objectivity of the trials, the researchers conducted 
sensitivity and random effects meta-analyses.  
After the trials the results show that in combining all the trials, subjects who 
received oral calcium supplements had a much larger significant decrease in their 
systolic blood pressure in comparison to the control group of subjects but not in the  
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diastolic blood pressure. The mean difference between the two groups’ systolic  
blood pressure was -2.5mmHg, 12=42%, 95% Cl: -4.5 to -0.6. 
This study contributes to some extend to ascertaining the role of serum calcium in 
maintaining blood pressure in adults by generating a small reduction in the systolic 
blood pressure but little effect on the diastolic blood pressure after studying the 
trials and the follow-up done by the researchers. This result is in line with results of 
a meta-analysis previously conducted by Allender in 1996, Bucher in 1996 and 
Griffith in 1999.  
The DASH Trial conducted in 1999 and in 2000 showed significant decrease in 
blood pressure after 8 weeks follow-up among participants with high blood 
pressure, who were on a diet that was high in calcium intake in comparison to 
those of the control group whose diet was low in calcium.  
Sura Sagban et al., in the year 2011 conducted a research to determine the effect of 
calcium carbonate taken orally by pregnant women with slightly high blood 
pressure which is also known as pre-eclampsia. As this condition of hypertension 
is the most common complication during pregnancy which poses a great health risk 
for both the infant and the mother, various metabolism studies are being done on 
how to regulate maternal blood pressure and also it is being determined on whether 
the oral intake of calcium reduces high blood pressure. The study by Sura Sagban 
et al., was done in order to evaluate and compare the level of calcium in high blood  
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pressure induced by pregnancy and in healthy pregnant women with normal blood 
pressure, and also to evaluate the effect of calcium taken orally by pregnant women 
with slightly high blood pressure, which is also referred to as mild pre-eclampsia. 
This study also was done to find out if there are any correlation between the effect 
of orally taken calcium supplements and the change in the concentration of serum 
calcium.  
For this study 45 pregnant women in their third trimester were selected and 
grouped into 15 healthy pregnant women with normal blood pressure as the control 
group, 30 pregnant women with slightly high blood pressure out of which 15 of 
them are untreated and 15 of them are treated with calcium carbonate of 500mg 
twice daily.  
After the test period, the results showed that the concentration of serum 
calcium in women with slightly high blood pressure was quite low as compared to 
those women with normal blood pressure. Also it was observed that the level of 
serum calcium showed significant rise in those pregnant women with slightly high 
blood pressure who were administered oral supplements of calcium carbonate of 
500mg twice daily in comparison to those women with slightly high blood pressure 
who were not treated any calcium carbonate. The blood pressure value and the SBP 
and the DBP was observed to have greatly decreased after a month’s time of 
treatment with calcium carbonate of 500mg taken twice daily in contrast to slightly 
high blood pressure group of pregnant women who were not treated, respectively.  
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The results that were obtained also showed that the concentration of serum calcium 
level in those women with slightly high blood pressure is much lesser than those 
women with normal blood pressure during their pregnancy. This suggests that 
calcium supplement taken orally can be beneficial in regulating blood pressure by 
increasing its intake. Also that reducing calcium intake during pregnancy can cause 
rise in blood pressure which is also called pre-eclampsia and that supplementing 
this nutrient may prevent pre-eclampsia by regulating the blood pressure.  
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 4.  METHODOLOGY 
Study population: A total of 100 subjects, of which 50 cases of essential 
hypertension satisfying inclusion and exclusion criteria visiting medicine OPD and 
admitted in Govt. Rajaji hospital, Madurai and 50 age and sex matched 
normotensive controls from 1
st
 June 2014 to 30
th
 November 2014 were taken up for 
study.  
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PROFORMA 
 
Name:       OP/IP No.: 
 
Age:        Hospital: GRH, Madurai 
 
Sex:        Date of Examination: 
 
Occupation:      Case / Control No.: 
 
Address: 
 
Socioeconomic status: Low/Middle/High 
 
 
Presenting Complaints: 
 
 
Headache 
    Palpitation 
 
Chest Pain 
 
 
Giddiness 
 
 
Blurring of vision 
 
 
Oedema 
 
 
Stroke 
 
 
Onset and Duration of Hypertension: 
 
 
Drug Treatment: If any 
 
 
Symptoms of Target Organ involvement: If any 
 
 
Past history: 
 
 
H/o Diabetes, IHD, Tuberculosis, Renal disease, CVA in the past. 
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    Family History : 
 
a) H/o Hypertension Yes/ No 
 
b) H/o Diabetes Mellitus Yes/ No 
 
 
Personal history: 
 
1. Diet –Veg / Mixed 
 
2. Sleep – Normal / Decreased 
 
3. Bowel and bladder habits – Regular / Disturbed 
 
4. Alcohol consumption – Yes / No; if yes, then 
 
Duration - Amount - Frequency - 
 
5. Smoking – Yes / No; if yes, then 
 
Duration - Frequency – 
 
 
Menstrual History : 
 
 
General physical examination: 
 
· Height : Weight: BMI: 
 
· Nourishment – Well / Moderate / Poor 
 
· Built – Well / Moderate / Poor 
 
· Pallor / Icterus / Clubbing /Cyanosis/ Lymphadenopathy / Oedema 
 
· Thyroid swelling 
 
 
Vitals: 
 
· Pulse   : Rate, rhythm , volume , character 
 
· Blood pressure   : Sitting 
 
Standing 
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· Respiratory rate: 
 
 
Systemic examination : 
 
a) Cardiovascular System: 
 
b) Respiratory System: 
 
c) Per abdomen : 
  
d) Central nervous system: 
 
 
 
Clinical diagnosis: 
 
 
 
 
 
Study profile: 
 
 Serum total calcium 
 
 Serum phosphorus 
 
 Serum calcium / phosphorus ratio 
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INCLUSION CRITERIA :  
 Patients with Newly diagnosed Essential hypertension 
 Patients whose age is above 18 years are included 
 Both sexes are included 
  
EXCLUSION CRITERIA :  
 Patients who are below 18 years 
 Patients who are on Vitamin D and Calcium supplementation 
 Patients with  Primary kidney disease/Chronic Kidney disease 
 Chronic Liver disease 
 Secondary Hypertension 
 Pregnancy 
 Drugs  influencing Calcium and Phosphorus metabolism  
JNC VII criteria was used to define hypertension in the study population. Cut 
off value for normotensives were taken as Systolic BP <120 mmHg and 
Diastolic BP <80 mmHg. Informed consent was taken from all the subjects. A 
detail history including diet, smoking and alcohol habits, lifestyle, drug and 
treatment history were taken into account. 
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MEASUREMENT OF BLOOD PRESSURE 
 
FIG 13: CORRECT TECHNIQUE FOR BP MEASURMENT 
Posture: Subject was kept in sitting position for 10 minutes with the back 
adequately supported, the arms were bared and kept approximately at the level 
of the heart. No tea, coffee, smoking, alcohol, medications were allowed for the 
previous 30 minutes. 
Environment: Subject was kept in a quiet and warm room with sufficient 
lighting. Recent meals and bowel / bladder evacuation was asked. Subject was 
reassured about the procedure to allay any anxiety. 
Blood pressure equipment: A mercurial based manual sphygmomanometer 
with adequate cuff size for adults encircling a minimum area of 80 percent of 
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 the arm and covering two thirds of its length was used. A space of 2.5 cm was 
kept between the anterior cubital fossa and the lower border of the cuff. 
Technique: Cuff pressure was elevated till the radial pulse disappeared. The 
bladder was deflated 2 mmHg per second and the first Korotkoff  sound heard 
was considered as systolic blood pressure and disappearance of Korotkoff sound 
phase 5 was considered as diastolic blood pressure. Two readings were taken at 
1 and 5 minutes respectively. Both the right and left arm pressures were 
measured and the mean taken into account. Details of the readings were noted 
down including the posture, arm used and pulse rate. 
Blood sample: 5 ml of non-hemolysed blood was drawn using a syringe from 
the ante cubital vein without the use of a tourniquet. The sample was 
immediately centrifuged for tests. 
Calcium: Total serum calcium was measured using arsenazo III reagent which 
is a highly sensitive and stable reagent. Serum calcium reacts with arsenazo III 
to form a purple coloured complex. Serum calcium was then measured using an 
automated analyzer. Calibration was done using  an aqueous Calcium Standard 
calibrator.  
Principle: 
Calcium + Arsenazo   Calcium-Arsenazo Complex  
        (purple colour)  
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Calculation: 
Abs. of sample         X Conc. of Standard = Calcium in mg/dl  
Abs. of standard  
For Example:  
 If the absorbance of sample = 0.91  
And absorbance of standard = 0.80 
 Concentration of standard = 10mg/dl 
 Then,    0.80    x 10  = 10.0 mg/dl  
    0.80  
 
Phosphorus: 
Serum phosphorus was measured using ammonium molybdate reagent in a 
slightly acidic medium. It reacts with the agent forming a phosphomolybdate 
complex which absorbs light at 350 nm wavelength. Calibration  was done 
using an appropriate standard calibrator. 
Principle:  
Phosphorus + H2SO4 + Ammonium molybdate  Unreduced 
Phosphomolybdate Molybdate Compound          
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Calculation: 
Absorbance of subject    x Conc. of sandardtd = Inorganic Phosphorus  in 
mg/dL          
Absorbance of Std.  
For Example: 
If  Absorbance of Subject = 0.25 
    Absorbance of Standard = 0.29 
   Concentration of Standard = 5 mg/dl  
then,    0.25    x  5 =  4.3  mg/dl  
             0.29  
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5. RESULTS 
The mean, median and standard deviation of the study population on 
various parameters are given below in the table. 
  BMI AGE 
CALCIUM 
(mg/dl) 
PHOSPHORUS 
(mg/dl) CP RATIO 
Mean 22.54 44.06 8.88 3.17 2.9182 
Median 21.9 43 8.8 3.2 2.71 
Standard 
Deviation 2.784 11.748 0.573 0.6472 0.62272 
Minimum 18 18 8 1.9 2.11 
Maximum 31 78 10 4.3 4.59 
 
TABLE 5: Mean, median and standard deviation of the participants 
 
The age distribution of the participants is given below in the table. 2. 36% of the 
participants were in the age group 18 – 39 years, 55% of the population was in 
the age group 40 – 59 years, while 9% of the population was in age group of 60 
years and above. 
TABLE 6: AGE DISTRIBUTION OF THE PARTICIPANTS 
AGE (Years) 
  Frequency Percent 
     18-39  36 36 
     40-59  55 55 
         >=60 9 9 
         Total 100 100 
    
FIG 14: AGE DISTRIBUTION OF THE PARTICIPANTS 
The sex distribution of cases and control is given in the table 3 below. Among 
the cases, 24 participants were females while 26 participants were male which 
was statistically significant ( p value 0.04). Among the controls, both the males 
and females were equal with 25 participants each. 
SEX 
  CASES CONTROLS   
FEMALE 24 25 49 
  48.00% 50.00% 49.00% 
MALE 26 25 51 
  52.00% 50.00% 51.00% 
Pearson Chi-Square: 0.04 ; p Value: 0.841 
TABLE 6: SEX DISTRIBUTION OF THE STUDY POPULATION                                                     
AGE DISTRIBUTION(%)
18-39
40-59
>60
  
0
5
10
15
20
25
30
Male Female
CASES
CONTROLS
FIG 15: SEX DISTRIBUTION OF THE STUDY POPULATION 
 
The median age of the study population was 44.  62% of the cases were less 
than the median, while 36% of the control were less than median. On the other 
hand, 38% of the cases and 64% of the control were above the median. 
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  CASES CONTROLS TOTAL 
AGE(Years) 
>=44 31 18 49 
  62.00% 36.00% 49.00% 
<44 19 32 51 
  38.00% 64.00% 51.00% 
  50 50 100 
  CUT OFF USING MEDIAN AGE 
Pearson Chi-Square: 6.763; ODDS RATIO: 2.901; 95% CI: 1.288 – 6.534; p Value: 0.009* 
TABLE 7: MEDIAN AGE OF THE PARTICIPANTS 
 
Out of the total participants, 20 % of the cases were under “overweight” 
category and 4.40 % were under “obese” category, while 10.2 % of the controls 
were overweight  and 2.1% were obese, the p value being 0.06. 
    CASES CONTROLS TOTAL 
BMI 
<18.49 1 0 1 
  2.20% 0.00% 1.10% 
18.5-24.49 33 44 77 
  73.30% 89.80% 81.90% 
25-29.99 9 5 14 
  20.00% 10.20% 14.90% 
30-34.99 2 0 2 
  4.40% 0.00% 2.10% 
    45 49 94 
TABLE 8: BMI OF CASES AND CONTROLS 
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CASES
<18.49
18.5-24.49
25-29.99
30-34.99
 
CONTROL
<18.49
18.5-24.49
25-29.99
30-34.99
FIG 16: BMI OF STUDY POPULATION 
               CASES          CONTROLS        TOTAL 
BMI 
      >=25 11 5 16 
  24.40% 10.20% 17.00% 
       <25 34 44 78 
  75.60% 89.80% 83.00% 
  45 49 94 
Pearson Chi-Square: 3.368; OR: 2.847; 95% CI: 0.903 - 8.973; p Value: 0.066 
TABLE 9:  NORMAL AND OBESE/OVERWEIGHT OF THE 
PARTICIPANTS 
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Out of all the participants, 60 % of the cases showed decreased serum level 
while 24 % of the controls showed decreased serum calcium level with p value 
<0.001. Only 40% of the cases had normal serum calcium level while 76 % of 
the controls had normal serum calcium level. (Pearson Chi-Square: 13.3, OR: 
4.75; 95%: 2.008 – 11.236; p Value: <0.001) 
             CASES     CONTROLS        TOTAL 
SERUM 
CALCIUM  
(mg/dl) 
      <8.07 30 12 42 
  60.00% 24.00% 42.00% 
      >=8.07 20 38 58 
  40.00% 76.00% 58.00% 
  50 50 100 
CUTOFF USING LOWER LIMIT OF RANGE 
Pearson Chi-Square: 13.3, OR: 4.75; 95%: 2.008 – 11.236; p Value: <0.001 
TABLE 10: SERUM TOTAL CALCIUM OF THE PARTICIPANTS 
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FIG 17: SERUM TOTAL CALCIUM IN CASES AND CONTROL 
 
            CASES     CONTROLS         TOTAL 
 CP RATIO 
     ≥  4.09 11 0 11 
  22.00% 0.00% 11.00% 
        <4.09 39 50 89 
  78.00% 100.00% 89.00% 
  50 50 100 
CUTOFF USING UPPER LIMIT OF RANGE 
Pearson Chi-Square: 12.36; p Value: <0.001 
TABLE 11: CALCIUM PHOSPHORUS RATIO IN CASES AND      
CONTROLS 
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FIG 18: GRAPH SHOWING CALCIUM PHOSPHORUS RATIO IN CASES 
AND CONTROLS 
 
 
 
 
            CASES        CONTROLS         TOTAL 
CP RATIO 
           >2.7 35 17 52 
  70.00% 34.00% 52.00% 
           <2.7 15 33 48 
  30.00% 66.00% 48.00% 
  50 50 100 
CUTOFF USING MEDIAN 
Pearson Chi-Square:12.981; OR: 4.529; 95% CI: 1.952 – 10.508; p Value: <0.001* 
TABLE 12: CALCIUM PHOSPHORUS RATIO USING LOWER LIMIT AS 
CUT OFF RANGE 
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 FIG 19:GRAPH SHOWING CP RATIO BETWEEN CASES AND 
CONTROLS 
28% of the cases had a positive family history of hypertension while 72% did 
not have any family history. Among the control, only 12% had family history of 
hypertension while 88% of them did not have any positive family history. 
Although, the association of positive family history of hypertension was slightly 
stronger with cases, we did not find it statistically significant (p Value: 0.046) 
              CASES        CONTROLS             TOTAL 
FAMILY 
HISTORY 
            YES 14 6 20 
  28.00% 12.00% 20.00% 
             NO 36 44 80 
  72.00% 88.00% 80.00% 
  50 50 100 
Pearson Chi-Square: 4; OR: 2.582; 95% CI: 0.995 – 8.173, p Value: 0.046* 
TABLE 13: POSITIVE FAMILY HISTORY BETWEEN CASES AND CONTROLS 
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 36% of the cases were smokers and 64% were non smokers. On the other hand, 
32% of the control were smokers and 68% did not have any history of smoking. 
Similarly, smoking has only a slightly stronger association with Cases but we 
did not find it statistically significant (p Value: 0.673). 
    CASES CONTROLS TOTAL 
SMOKER 
YES 14 6 20 
  36.00% 32.00% 34.00% 
NO 32 34 66 
  64.00% 68.00% 66.00% 
  50 50 100 
Pearson Chi-Square: 0.178; OR: 1.195; 95% CI: O.522 – 2.737, p Value: 0.673 
TABLE 14: SMOKING HABITS IN CASES AND CONTROLS 
In our study population, 28% of both cases and control were alcoholics while 
72% of them were non-alcoholics. The association of alcohol in cases and 
control was equal and statistically not significant. 
            CASES       CONTROLS         TOTAL 
ALCOHOL 
          YES 14 14 28 
  28.00% 28.00% 28.00% 
           NO 36 36 72 
  72.00% 72.00% 72.00% 
    50 50 100 
Pearson Chi-Square: 0; p Value: 1.0 
TABLE 15: ALCOHOL HABIT IN CASES AND CONTROLS 
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28% of the participants who had BMI  > 25 had serum calcium less than 8.07 
mg/dl while only  9.10 % with normal serum calcium level had BMI more than 
25. 71% of the participants who had BMI < 25 had decreased serum calcium 
while 90% of the participants with BMI less than 25 had normal serum calium. 
(p Value: 0.015*).  In the participants, we observed that a higher percentage of 
participants who are obese or overweight had lower calcium level rather than 
normal serum calcium which was statistically significant.  
  
CALCIUM (mg/dl)   
          <8.07               >8.07         TOTAL 
BMI 
          >25 11 5 16 
  28.20% 9.10% 17.00% 
          <25 28 50 78 
  71.80% 90.90% 83.00% 
  39 55 94 
Pearson Chi-Square: 5.903; OR: 3.929; 95% CI: 1.239  - 12.456; p Value:0.015* 
TABLE 16: ASSOCIATION OF BMI AND SERUM TOTAL CALCIUM 
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In our study, 64.30% of the participants who were above 44 years had low 
serum calcium while 37.90% had normal serum calcium level. 35.70% of the 
participants who were below 44 years had low serum calcium and 62.10% of 
the participants in this category had normal serum calcium. This shows that 
older people are more likely to have low serum total calcium as compared to 
younger age group. (p Value: 0.009*) 
  
CALCIUM (mg/dL)   
            <8.07            >8.07             TOTAL 
AGE 
        >44 27 22 49 
  64.30% 37.90% 49.00% 
        <44 15 36 51 
  35.70% 62.10% 51.00% 
  42 58 100 
Pearson Chi-Square: 6.771; OR: 2.945; 95%: 1.292 – 6.717; p Value: 0.009* 
TABLE 17: AGE DISTRIBUTION WITH SERUM TOTAL CALCIUM 
In our study, 50% of the obese/overweight individuals had serum calcium 
phosphorus ratio more than 4.09 and 13.10% had serum calcium phosphorus 
ratio less than 4.09. 50% of the participants with normal weight had serum 
calcium phosphorus ratio more than 4.09 while 86% of the participants in this 
category had serum calcium phosphorus less than 4.09. This shows that subjects 
who are obese/overweight are more strongly associated with an increased C:P  
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ratio as compared to subjects with normal body weight which was statistically 
significant. (p Value: 0.003*) 
TABLE 18: ASSOCIATION OF BMI AND CALCIUM PHOSPHORUS RATIO 
  
CALCIUM PHOSPHORUS(CP) RATIO   
         >4.09          <4.09               TOTAL 
BMI 
            >25 5 11 16 
  50.00% 13.10% 17.00% 
            <25 5 73 78 
    50.00% 86.90% 83.00% 
    10 84 94 
Pearson Chi-Square: 8.617; OR: 6.636; 95% CI: 1.649 – 26.705; p Value: 0.003* 
FIG 21: GRAPH SHOWING ASSOCIATION OF BMI WITH CP RATIO 
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 Multivariate analysis by logistic regression 
 
TABLE 19: Logistic regression model  for factors associated with 
hypertension 
MULTIVARIATE ANALYSIS 
Variable 
OR 
(unadjusted) 
95% C.I 
(unadjusted ) Chi 
Sq.P-
value 
OR 
(Adjusted) 
95% C.I. 
(adjusted ) 
Lower Upper 
Lowe
r 
Upper 
Female 0.923 0.421 2.022 0.81 0.88 0.33 2.4 
Serum calcium 
<8.07 mg/dl 
4.75 2.008 11.236 0.003* 4.61 1.66 12.81 
CP ratio > 2.7 4.529 1.952 10.508 0.002* 5.26 1.89 14.7 
Smoker 1.195 0.522 2.737 0.06 3.39 0.96 11.93 
BMI >=25 2.847 0.903 8.973 0.33 2.02 0.5 8.21 
Age >=44yrs 2.901 1.288 6.534 0.11 2.32 0.83 6.51 
 
To adjust for potential confounders, selected variables from the Univariate 
analysis were analyzed. A logistic regression model was derived by entering the 
following variables: Sex, serum calcium <8.07 mg/dl, CP ratio >2.7, smoking 
history. BMI>=25 and Age >=44years. In this regression model Serum calcium 
<8.07 mg/dl Adjusted OR 4.61 (95%CI 1.66-12.81 and CP ratio >2.7. 
Adjusted OR 5.26  (95%CI 1.89-14.7 are significantly associated with  
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hypertension after adjusting for confounding factors. 
In other words the odds of a patient with hypertension is  4.61 times more likely 
to have a serum calcium level less than 8.07 mg/dl as compared to a non 
hypertensive and the odds of a patient with hypertension to have a CP 
ratio>=2.7 is 5.26 more than that of a normotensive individual. 
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 7. DISCUSSION 
In our study, the age distribution of the participants were grouped into three 
categories. 2. 36% of the study population was in the age group 18 – 39 years, 
55% of the population was in the age group 40 – 59 years, while 9% of the 
population was in age group of 60 years and above. Among the three groups, 
age group 18-39 % had the lowest number of participants. This may be 
attributed to the fact that most hypertensive patients remain asymptomatic for 
many years and they seek medical attention only when complication sets in. As 
expected, participants from age group 40-59 were the highest as they began to 
develop hypertension related problems like end organ damage during this age.  
The sex distribution of cases and control is given in the table 3 below. Among 
the cases, 24 participants were females while 26 participants were male which 
was statistically not significant ( p value 0.04). Among the controls, both the 
males and females were equal with 25 participants each. In our study, we 
observed a slightly increased number of male participants but it was not 
significant. Therefore, our observation is that both males and females are almost 
equally affected, especially in the middle age. 
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The median age of the study population was 44.62% of the cases were less than 
the median, while 36% of the control were less than median. On the other hand, 
38% of the cases and 64% of the control were above the median. 
Out of the total participants, 20 % of the cases were under “overweight” 
category and 4.40 % were under “obese” category, while 10.2 % of the controls 
were overweight and 2.1% were obese, the p value being 0.06 which was 
statistically not significant in relation to hypertension. However we observed 
that over weight/obese individuals tend to have decreased serum calcium level 
which was statistically significant. (p Value: 0.015*). Thus BMI may be an 
independent risk factor for low serum calcium.  
In our study, 86% of the participants with C:P ratio in normal range had normal 
BMI, while only 13.10% of the overweight/obese participants had C:P ratio in 
the normal range which was statistically significant. (p Value:0.003*) 
In the study population, 60 % of the cases showed decreased serum level while 
24 % of the controls showed decreased serum calcium level with p value 
<0.001. Only 40% of the cases had normal serum calcium level while 76 % of 
the controls had normal serum calcium level. (Pearson Chi-Square: 13.3, OR: 4.75; 
95%: 2.008 – 11.236; p Value: <0.001). This is in agreement with studies done various 
authors like Jha et al[7] where they concluded that serum total calcium is  
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decreased in hypertensive subjects as compared to normotensives. 
Touyz et al [2] also observed a significantly decreased level of serum calcium in 
hypertensive individuals along with decreased serum potassium and decreased 
serum magnesium. Yogesh et al [13] mentioned that serum ionised calcium 
calcium was decreased in hypertension but no significant correlation exists 
between serum total calcium and hypertension. Our finding is also in 
accordance with studies done by Stern et al [5], Takale et al [3], Sharma et al[9], 
Sudhakar et al [4]. However, in a study done by Hazari and associates [10], they 
could not find any significant association of both serum calcium and serum 
ionized calcium with hypertension. 
36% of the cases were smokers and 64% were non smokers. On the other hand, 
32% of the control were smokers and 68% did not have any history of smoking. 
Similarly, smoking has only a slightly stronger association with Cases but we 
did not find it statistically significant (p Value: 0.673) 
In our study population, 28% of both cases and control were alcoholics while 
72% of them were non-alcoholics. The association of alcohol in cases and 
control was equal and statistically not significant (p Value: 1). This is in 
contrast to the observations made by Danni and associates[29], Klatsy [30] who 
opined that alcohol may serve as an independent risk factor for hypertension. 
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28% of the cases had a positive family history of hypertension while 72% did 
not have any family history. Among the control, only 12% had family history of 
hypertension while 88% of them did not have any positive family history. 
Although, Sudhakar et al [4], and Sharma [18] concluded that serum calcium 
was decreased in the first degree relatives of hypertensive individuals as well, 
we observed that the association of positive family history of hypertension was 
only slightly stronger with cases, and we did not find it statistically significant 
(p Value: 0.046)          
  Using the multivariate analysis, we observed that participants with 
low serum total calcium are significantly associated with hypertension after 
adjusting for confounding factors. 
In other words the odds of a patient with hypertension is  4.61 times more likely 
to have a serum calcium level less than 8.07 mg/dl as compared to a non 
hypertensive individual and the odds of a patient with hypertension to have a 
CP ratio >2.7 is 5.26 more than that of a normotensive individual. 
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 7. SUMMARY 
 Majority of our patients were in the age group of 40 – 55. 
 Males outnumbered females slightly. 
 Most of the patients had normal body mass index. 
 Positive family history had only a slight association with essential 
hypertension. 
 Obesity may be an independent risk factor for low serum calcium. 
 Smoking and alcohol habits did not show any relationship with essential 
hypertension. 
 There was a significant association between serum total calcium, serum 
calcium / phosphorus ratio with essential hypertension. 
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8. CONCLUSION 
. Hypertension is an emerging health problem in India. Hypertension 
significantly increases the risk of mortality and morbidity of 
cerebrovascular accidents (both ischaemic and haemorrhagic), coronary 
artery disease, congestive heart failure, chronic kidney failure, and 
peripheral vascular diseases. When majority of people come to know that 
they have hypertension they have already advanced into a stage with 
target organ damage - a fatal stroke or myocardial infarction or 
irreversible renal failure. In addition to a primary increase in cardiac 
function propelled by increased activity in the sympathetic nervous 
system, primary retention of cations and water by kidney, other factors 
contributing to hypertension are genetic predisposition, low serum 
calcium level, high Sodium and low excretion, low Potassium and low 
calcium intake and increased excretion. Many recent studies have 
implicated serum calcium level in the role of development of 
hypertension and increasing evidence are emerging supporting this 
theory. This tendency has been observed even in pregnant women. Thus, 
in addition to the routine dietary restriction salt in hypertensive 
individuals, estimation of serum calcium level and calcium / phosphorus 
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ratio may be considered in patients with essential hypertension when 
planning for a treatment strategy and addition of oral calcium supplement 
in diet may offer a favourable outcome. 
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 9. LIMITATIONS  
 In this study, Although patients with associated comorbidities which are 
likely to affect serum albumin were excluded, however, serum total 
calcium level was not corrected for serum albumin. 
 Small sample size of the study. 
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MASTER CHART  
CASES 
SR. 
NO. NAME AGE SEX BMI 
BP 
(mmHg) 
SR. CALCIUM 
(mg/dl) 
SR. 
PHOSPHORUS 
(mg/dl) 
C : P 
RATIO 
FAMILY 
HISTORY SMOKER ALCOHOLIC 
1 PANCHAVARNAM 45 F 21.14 
152 / 
108 9.5 3 3.1 NO NO NO 
2 KATHIRASEN 58 M 22.1 
166 / 
106 8.1 3.8 2.23 NO YES YES 
3 RAMASMY 54 M 23.14 
192 / 
112 8.6 2.1 4.09 YES YES YES 
4 MARRIAMAL 50 F 19.3 
154 / 
106 8.9 2.3 3.86 YES NO NO 
5 CHELLAMAL 55 F 20.1 
148 / 
96 9.5 3.2 2.96 NO NO NO 
6 RAKKAMAL 41 F 20.71 
158 / 
102 8.6 2.1 4.09 YES NO NO 
7 VEERAMMAL 55 F 21 
156 / 
100 9.2 3.4 2.7 NO NO NO 
8 ARUL 32 M 23.63 
210 / 
116 8.2 2.6 3.1 NO YES YES 
9 NANDHINI 18 F 22.1 
164 / 
104 9.6 3.9 2.46 NO NO NO 
10 MUTHU 40 M 21.1 
166 / 
110 8.1 2.2 3.68 YES YES NO 
11 BASKARN 61 M 22.14 
140 / 
102 9 3 3 NO NO NO 
12 NATARAJAN 78 M 20.8 
210 / 
120 8.3 2 4.15 NO NO NO 
13 KRISHNA 62 M 22.12 
142 / 
98 8.2 2.4 3.41 YES YES YES 
14 DURAI RAM 41 M 19.88 
154 / 
106 8.5 2 4.3 NO YES YES 
15 ALEX 36 M 21.12 
160 / 
100 8.3 2.4 3.45 NO YES YES 
16 PONNUTHAI 39 F 22.21 
142 / 
96 8 2.3 3.47 NO NO NO 
17 KALIAMMAL 44 F 27.12 
150 / 
108 8.4 2.8 3 NO NO NO 
18 POOCHANDU 31 F 26.13 
162 / 
112 8.5 2 4.25 NO NO NO 
19 SURESH 40 M 20.1 
144 / 
100 10.1 3.8 2.65 NO YES YES 
20 MD. YUSUF 34 M 29.12 
166 / 
104 9.1 2.7 3.37 NO YES NO 
21 SARITHA 45 F 28.34 
146 / 
100 9.7 4 2.4 NO NO NO 
22 ROSEMARY 25 F 19.23 
152 / 
100 8.4 2.6 3.23 NO NO NO 
23 MUTHUSAMY 43 M 30 . 12 
162 / 
102 8.8 2.1 4.19 YES YES NO 
24 SEETHALAKSHMI 38 F 22.12 
150 / 
110 9 2.7 3.33 NO NO NO 
25 SHARADHA 66 F 31.43 
168 / 
116 8 1.9 4.21 NO NO NO 
26 REVATHI 42 F 21.4 
148 / 
106 9.2 3.9 2.35 NO NO NO 
27 PRABHU 44 M 18. 98 
144 / 
100 8.9 2.9 3.06 YES NO NO 
28 GOVINDARAJ 50 M 28.34 
180 / 
114 8.6 2 4.3 NO YES YES 
29 LAKSMI 33 F 21.1 
162 / 
108 8.9 3.1 2.87 YES NO NO 
30 MOOVINDRAN 55 M 27.13 
156 / 
106 8.6 3.7 2.32 YES YES YES 
31 KARUPASAMY 48 M 18.14 
148 / 
100 8.8 4 2.32 YES NO NO 
32 KARTHIK 30 M 21.46 
152 / 
98 10.1 2.2 4.59 NO YES YES 
33 BOSE 45 M 22 
164 / 
100 8.4 3.8 2.21 NO NO YES 
34 LENIN 54 M 23. 64 
170 / 
110 8.5 2.4 3.5 NO NO NO 
35 KARTHIKEYAN 44 M 22.4 
162 / 
104 8.4 2.1 4 NO YES YES 
36 SUJATHA 48 F 31. 4 
168 / 
102 8.8 3.9 2.25 NO NO NO 
37 NIVEDHA 61 F 29.63 
158 / 
108 8.9 3.4 2.61 NO NO NO 
38 TAMILARASI 49 F 19.4 
156 
/98 8.3 2.7 3.07 NO NO NO 
39 SUNANTHA 55 F 24.3 
144 / 
102 8.3 3.8 2.18 YES NO NO 
40 INDUMATHI 43 F 21 
150 / 
104 8.7 3.2 2.71 NO NO NO 
41 JYOTHI 38 F 22.42 
154 / 
108 9.3 3 3.1 YES NO NO 
42 SUBRAMANIAM 54 M 28.4 
176 / 
124 8 2.1 3.8 NO YES YES 
43 SUBBULAKSHMI 67 F 27.6 
170 / 
120 8.4 2 4.2 NO NO NO 
44 JAGADISH 54 M 20.4 
150 / 
104 9 4.1 2.19 YES YES YES 
45 ALAGAR 56 M 19.4 
148 / 
102 8.7 3.9 2.23 NO YES NO 
46 PANDIYAN 49 M 22.46 
156 / 
110 8.6 2.4 3.58 NO NO NO 
47 RAMU 50 M 21.3 
150 / 
110 8.3 3.5 2.37 NO YES NO 
48 HASEENA BEGUM 54 F 31.4 
164 / 
112 8.3 2 4.15 NO NO NO 
49 JEYA 42 F 20.83 
160 / 
110 8.1 2.8 2.89 YES NO NO 
50 SHEIKH 56 M 21. 68 
154 / 
100 8.5 3.3 2.57 NO NO NO 
 
 
CONTROLS 
SR. 
NO. NAME AGE SEX BMI 
BP 
(mmHg) 
SR. CALCIUM 
(mg/dl) 
SR. PHOSPHORUS 
(mg/dl) 
C : P 
RATIO 
FAMILY 
HISTORY SMOKER ALCOHOLIC 
1 A 31 M 21.6 
118 / 
78 9.3 3.1 3 NO NO YES 
2 AA 42 M 22.1 
112 / 
70 9.5 3.5 2.71 NO NO NO 
3 B 33 F 19.64 
110 / 
70 9 3.5 2.57 NO NO NO 
4 BB 40 M 20.44 
106 / 
72 8.9 3 2.96 NO YES NO 
5 C 51 M 21.7 
114 / 
70 9.7 3.5 2.77 NO YES YES 
6 CC 45 M 22 . 4 
118 / 
74 8.4 3.2 2.65 NO YES YES 
7 D 54 M 19.8 
110 / 
70 8.3 3.1 2.67 NO NO NO 
8 DD 57 M 22.6 
116 / 
74 9.1 3.9 2.33 NO NO NO 
9 E 28 M 20.4 
104 / 
68 9.4 2.9 3.24 NO NO NO 
10 EE 30 F 21.5 
100 / 
68 10.1 3.8 2.65 NO NO YES 
11 F 43 F 22.8 
110 / 
70 10.3 4 2.57 NO NO NO 
12 FF 41 F 20.6 
116 / 
76 8.2 3.6 2.27 YES NO NO 
13 G 56 M 25.2 
118 / 
76 8.9 4.2 2.11 NO NO NO 
14 GG 62 F 26.2 
118 / 
78 8.2 3.7 2.21 NO NO NO 
15 H 34 F 23.4 
110 / 
70 8.6 3.6 2.38 NO NO NO 
16 HH 43 F 20.6 
102 / 
74 9.3 2.9 3.2 NO NO NO 
17 I 50 M 22.4 
108 / 
70 9.8 3 3.26 NO YES YES 
18 II 23 M 21 
100 / 
64 9.1 3.7 2.45 NO YES NO 
19 J 34 F 19.8 96 / 64 8.7 3.3 2.63 NO NO NO 
20 JJ 36 M 20.8 
102 / 
68 9.6 3.8 2.52 YES YES YES 
21 K 31 F 24.8 
108 / 
74 8.5 3.9 2.17 NO YES NO 
22 KK 43 F 22 
110 / 
70 8.8 3.2 2.75 NO NO NO 
23 L 27 F 19.8 96 / 70 9.3 3.5 2.65 NO NO NO 
24 LL 29 M 21.8 
100 / 
72 9.6 3.1 3.09 YES YES NO 
25 M 32 M 22.6 
106 / 
76 8.9 3.6 2.47 NO YES YES 
26 MM 43 F 21.6 
106 / 
70 8.8 3.8 2.31 NO NO NO 
27 N 33 F 20.8 
100 / 
70 9.4 4 2.35 NO NO NO 
28 NN 36 F 21.4 92 / 66 9.2 3.7 2.48 NO NO NO 
29 O 60 M 26.4 
118 / 
78 8.2 3.1 2.64 NO YES YES 
30 OO 68 F 23.6 
100 / 
70 8.6 3.8 2.26 NO NO NO 
31 P 45 M 21.4 
104 / 
74 9.1 3.8 2.39 NO YES YES 
32 PP 24 F 19.2 98 / 70 9.4 3.5 2.68 NO NO NO 
33 Q 36 F 25.6 
100 / 
72 8.2 3.5 2.34 NO NO NO 
34 QQ 52 F 23.1 
112 / 
74 8.9 3.6 2.47 NO NO NO 
35 R 44 M 22 
108 / 
70 9.2 2.8 3.28 NO YES YES 
36 RR 34 M 23.4 
110 / 
78 9.3 3.5 2.65 NO YES NO 
37 S 22 M 22.6 
118 / 
78 10.3 4.3 2.39 YES NO YES 
38 SS 33 F 22.5 
108 / 
74 9.2 3.2 2.87 NO NO NO 
39 T 55 M 21.8 
110 / 
78 8.2 2.5 3.28 NO NO NO 
40 TT 54 F 20.4 
106 / 
72 8.8 3.1 2.83 NO NO NO 
41 U 36 F 22.06 
108 / 
72 9 3.2 2.81 YES NO NO 
42 UU 57 F 21 
110 
/76 8.1 2.9 2.79 NO NO NO 
43 V 46 M 27.08 
116 / 
78 8.7 3.6 2.41 YES YES YES 
44 VV 25 M 19.7 
106 / 
70 10.1 3.9 2.58 NO YES YES 
45 W 59 F 23.7 
116 / 
76 8.9 3 2.96 NO NO NO 
46 WW 34 M 21.09 
104 / 
76 9.4 3.7 2.54 NO YES YES 
47 X 35 M 23.11 
106 / 
72 8.3 3.4 2.44 NO NO NO 
48 XX 57 F 20.8 
110 / 
78 8.8 3.6 2.44 NO NO NO 
49 Z 39 M 21.6 
114 / 
70 9.8 3.9 2.51 NO NO NO 
50 ZZ 32 F 22.8 
116 / 
72 9.6 3.5 2.74 NO NO NO 
      
443.4 
      
